BIBLIOGRAFÍA RECOMENDADA
1. Louzada M, Majeed H, Wells P. Efficacy of Low-molecular-weight-heparin versus Vitamin K antagonists for long term treatment of cancer-associated venous thromboembolism in adults: A systematic review of randomized controlled trials. Thrombosis Research 2009; 123(6): 837-844.

2. Ferretti G, Bria E, Giannarelli D, Carlini P, Felici A, Mandala M, Papaldo P, Fabi A, Ciccarese M, Cuppone F, Cecere FL, Nuzzo C, Terzoli E, Cognetti F. Is recurrent venous thromboembolism after therapy reduced by Low-Molecular-Weight Heparin compared with oral anticoagulants? Chest 2006; 130: 1808-1816.

3. Pérez-de-Lano L, Leiro-Fernández V, Golpe R, Núñez-delgado JM, Palacios-Bartolomé A, Méndez-Marote L, Colomé-Nafria E. Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study. Blood Coagul Fibrinolysis 2010; 21:744-749.

4. González-Fajardo, JA, Arreba E, Castrodeza J, et al. Venographic comparison of subcutaneous low-molecular-weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous trombosis. J Vasc Surg 1999; 30: 283-290.

5. Romera A, cairols MA, Vila-Coll R, et al. A randomized open-label trial comparing long-term subcutaneous low-molecular-weight heparin compared with oral anticoagulant therapy in the treatment of deep venous trombosis. Eur J Vasc Endovasc Surg 2009; 37:349-356.

6. Hull RD, Pineo GF, Brant RF. For the LITE Trial Investigators. Long-term low-molecuar-weight heparin versus usual care in proximal-vein trombosis patients with cancer. Am J Med 2006; 119:1062-1072.

7. López-Beret P, Orgaz A, Fontcuberta J, et al. Low-molecular-weight heparin versus oral anticoagulant in the long-term treatment of deep venous trombosis. J Vasc Surg 2001;33:77-90.

8. Lee A, Lenine M, Baker R, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003;349:146-153.

9. Hyers TM, Agnelii G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119:Suppl:176S-193S.

10. Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, SchünemannH. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.:CD006650. DOI:10.1002/14651858.CD006650.pub2.